Toronto, Ontario, September 21, 2015 – The Ontario Bioscience Innovation Organization (OBIO®) is pleased to recognise Johnson & Johnson Innovation’s major contribution to Ontario’s human health bioscience ecosystem through the choice of Toronto as the first ex-US Johnson & Johnson Innovation, JLABS site. The JLABS incubator model is the highly successful creation of Johnson & Johnson Innovation and has been brought to Canada with the help of Janssen Inc. Known as JLABS @ Toronto, the site will join its fellow JLABS sites in San Diego, San Francisco, Boston and Houston.
The Ontario Bioscience Innovation Organization (OBIO) works to advance the development and growth of a sustainable, commercially - driven, life sciences industry in Ontario. OBIO is a private sector, membership-based organization representing Ontario’s human-health bioscience industry. Key among Ontario's bioscience strengths are a pipeline of high value, early stage intellectual property and start-up opportunities. In addition, Ontario boasts a strong academic research base with significant investment in intellectual-property generation and research training.
Ontario’s human health bioscience industry consists of almost 100 small and medium-size companies of which over 50 per cent are working on therapeutic products. Forty per cent of companies are located in the Greater Toronto Area with access to eight universities, 10 colleges, 60 hospitals and an innovative business incubator (MaRS Discovery District)... [more]
Click here to view the full article in PDF format, by Gail Garland in Vantage GTA, Spring Summer 2011.